Table 8. AADs for pharmacological cardioversion25) .
Drug | Route | Dosage | Risks |
---|---|---|---|
Amiodarone | Oral | Oral 600–800 mg daily in divided doses to a total load of up to 10 g, then 200 mg q.d. as maintenance | Gastrointestinal upset, constipation, bradycardia/AV block, hypotension, QT prolongation, torsades de pointes (rare), phlebitis (IV), increased INR |
IV | 150 mg over 10 minutes, then 1 mg/min for 6 hours, then 0.5 mg/min for 18 hours or change to oral dosing | ||
Flecainide | Oral | 200–300 mg | Atrial flutter with 1:1 AV conduction, ventricular proarrhythmia, hypotension |
Propafenone | Oral | 450–600 mg | Atrial flutter with 1:1 AV conduction, ventricular proarrhythmia, hypotension |
AAD = antiarrhythmic drug; AV = atrioventricular; INR = international normalized ratio; IV = intravenous; q.d. = once a day or once daily.